| Code: MTA10042 | Publication Date: Oct 2025 |
The key factors contributing to this growth include the growing prevalence of chronic and infectious disease cases, improvements in diagnostic technologies, increasing need for high-throughput screening products, and the increasing use of automated immunoassay analysers within healthcare and research laboratories.
The Immunoassay Market trends align with the growth of a trend toward greater automation and the incorporation of advanced analytical software to enhance efficiencies and improve accuracy. The trend toward the greater use of chemiluminescent and fluorescence-based assays, due to their high sensitivity, is increasing. There are increasing trends toward miniaturisation and flexible forms of portable diagnostics for near-patient testing, as well as a greater use of immunoassays within the areas of therapeutic drug monitoring, oncology, and endocrinology, supporting the growth of immunoassay funding in R&D.
The Immunoassay Market developments indicate ongoing innovation with AI-powered data interpretation and digital immunoassay systems enhancing diagnostic accuracy. Companies are investing in fully automated analyzers to streamline workflow and reduce human error. Partnerships between diagnostics firms and biotech companies are fostering product advancements. Additionally, sustainability initiatives focusing on reagent efficiency and waste reduction are being implemented. These developments are positioning immunoassays as a cornerstone of modern diagnostic solutions.
Some of the leading companies include: